Travaux subventionnés

Retour aux résultats

La faisabilité de l’IRM utilisant du 13C-pyruvate hyperpolarisé pour surveiller les patients ayant des métastases intracrâniennes

Aperçu du projet

Surgery and radiation are standard treatments for cancer that has spread to the brain. Recent research has revealed that cancer cells with high levels of the chemical lactate are aggressive and resist radiation therapy. Dr Charles Cunningham will study whether an enhanced imaging method that can detect lactate can help predict how cancer in the brain will behave. He will compare it to other routine imaging techniques used to assess patients before brain radiation therapy. This new method may help tailor treatment plans to prolong survival. This grant is funded in partnership with Brain Canada with the financial support of Health Canada.

Chef d'équipe

Charles Cunningham , Sunnybrook Research Institute

Partenaire et Donateurs

Canadian Cancer Society

Projet terminé

La faisabilité de l’IRM utilisant du 13C-pyruvate hyperpolarisé pour surveiller les patients ayant des métastases intracrâniennes

  • Type de programme

    Team grants

  • Domaine de recherche

    Cancer

  • Disease Area

    Brain Cancer

  • Compétition

    Canadian Cancer Society Innovation Grants

  • Province

    Ontario

  • Date de Début

    2017

  • Montant total du financement

    $187,915

  • Contribution Santé Canada

    $939,575